# Emertec

> Emertec is a VC fund in Grenoble backing Energy and Software. See 25 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Grenoble, France
- Total investments: 25
- Last investment: Oct 2017
- Lead investor: 8%
- Last updated: Aug 2026
- X (Twitter): https://twitter.com/infoemertec
- Website: http://www.emertec.fr

Emertec is a VC fund in Grenoble focused on Energy and Software. EMERTEC’s experienced investment team has developed proven track record and has been able to develop close ties with major industrial players, many of them also being investors in their funds.These close ties are extremely valuable as to understand medium and long-term requirements of major order placers and high-level commercial opportunities.This brings visibility and confidence for entrepreneurs as well as for its investors.Their objective is to create value by turning ground-breaking technological innovations into commercial and financial successful companies.

## Contacts

5 contacts available for Emertec. Shizune tracks 2 team members at Emertec. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/emertec-gestion?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1.4M–$6.8M |
| Series B | $5.8M–$15M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Energy | 4 | 16% |
| Software | 4 | 16% |
| Electronics | 4 | 16% |
| Biotechnology | 4 | 16% |
| Agriculture | 3 | 12% |

38 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 7 | 28% |
| Funding Round | 6 | 24% |
| Series B | 4 | 16% |
| Seed | 2 | 8% |
| Series C | 1 | 4% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 16 | 64% |
| Canada | 1 | 4% |
| United States | 1 | 4% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Franck Lamy | Investment Manager | 0 | https://shizune.co/investors/profile/franck-lamy |
| Jean-Philippe Gendre | Member, Board of Directors | 0 | https://shizune.co/investors/profile/jean-philippe-gendre |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Osmia | Osmia SAS provides crop pollination services to improve yield and quality of agricultural production. Osmia intervenes in the context of specific problems on entomophilous or anemophilic pollination. Methodological approach and experience enables the company to find relevant solutions. It offers pollination studies and services for pre-base, baseor multiplication seeds. It also offers simple and efficient pollination services for arboriculture and optimize the yields and the quality of the productions of fruit trees.Osmia SAS was founded on 2014 and is headquartered in France. | $1.1M |  | Oct 17, 2017 |  |
| Ynsect | Ynsect provides products and services that operate in the agro-food and environmental biotech industries. It uses the potential of insect nutrients and behaviors to develop novel products and services in collaboration with their clients. Since 2011, Ÿnsect has been transforming farmed insects into premium animal nutrition. They are developinginnovations to farm insects at large scale and automating processes to turn insects into the highest quality raw materials for animal feed. Its unique know-how makes Ÿnsect a preferred partner among agri-food professionals, laboratories, investors, public institutions, and insect industry farmers. | $15.2M | Series B | Dec 14, 2016 |  |
| eLichens | eLichens' mission is to provide relevant and comprehensive information about the air they breathe. The company relies on a portfolio of patents, know-how and skills that enable a complete air quality solution (sensors and services) and address both consumer electronics and industrial markets. eLichens has its offices in Grenoble, France andin the Silicon Valley California, USA. | $3.3M |  | Jul 29, 2016 |  |
| Deepki | Deepki is the most trusted sustainability solution for real estate. The complete SaaS platform helps asset owners and investors manage risk, enhance financial performance, and meet rising expectations from regulators and stakeholders with data-driven insights. They support clients in creating clear, actionable plans for both climate transition andadaptation—delivering quantifiable environmental and financial outcomes.With 600+ customers and 70,000 users, Deepki monitors €4T in assets across 90+ countries and 60+ asset types, serving clients such as Generali Real Estate, PGIM, Swiss Life, and the French government. Deepki holds both ISAE 3000 Type II and SOC 2 Type II reports, meeting the highest standards for data security, credibility and auditability.With 500+ customers and 50,000 users, Deepki monitors €4T in assets across 80+ countries and 60+ asset types, serving clients such as Generali Real Estate, PGIM, Swiss Life, and the French government. Their platform is also ISAE 3000 Type 2 certified, which meets the highest standards for data credibility and auditability. | $2.2M | Series A | Jun 23, 2016 |  |
| Naïo Technologies | Naio Technologies develops and markets machines for agriculture and viticulture. It features electric tools for weeding, hoeing, and harvesting that help farmers collect and harvest their products. The company specializes in agriculture, AI, robotics, and Agtech. Naio Technologies was founded in 2011 and headquartered in Midi-Pyrenees, France. | $3.3M | Seed | Dec 22, 2015 |  |
| Defymed | Defymed is a worldwide leader in the development of innovative implantable medical devices that change the paradigm of therapeutics' administration. Defymed's innovations were developed to limit adverse events related to current standard of care based on site specific delivery of therapeutics. Our solutions aim for a preciseadministration of drugs, in a physiologic site, in order to improve disease's management and patients' quality of life. Up to date, two first in class technologies were developed by Defymed: MailPan®, a physiologic cell encapsulation device, and ExOlin®, a targeted drug delivery device (in clinics). Defymed owns an exclusive technology and know-how which positions its medical devices as a platform to meet several therapeutic applications, among which type 1 diabetes, hemophilia and cancer management. Defymed is certified ISO13485:2016. Defymed relies also on a strong and unique worldwide network gathering experts from the cell therapy and drug delivery fields. Defymed has been rewarded several times in Europe and in the USA, for its unique approaches to reinvent patients' journey. | $2.7M | Seed | Oct 27, 2015 |  |
| Osmia | Osmia SAS provides crop pollination services to improve yield and quality of agricultural production. Osmia intervenes in the context of specific problems on entomophilous or anemophilic pollination. Methodological approach and experience enables the company to find relevant solutions. It offers pollination studies and services for pre-base, baseor multiplication seeds. It also offers simple and efficient pollination services for arboriculture and optimize the yields and the quality of the productions of fruit trees.Osmia SAS was founded on 2014 and is headquartered in France. | $531K |  | Sep 14, 2015 |  |
| Enerbee | EnerBee is an industrial start-up developing energy harvesters, which, thanks to motion, replace batteries in consumer and industrial smart devices.All of us are making extensive use of devices – like watches, remote controls, connected objects at home or with us, etc. – which requires batteries or plugs to be charged. More than 30 billion coincell batteries are sold every year throughout the world. EnerBee is industrializing a multi-patented motion-based generator, which replaces these batteries or cables to power wireless connected objects thanks to the motion. | $2.7M |  | Mar 13, 2015 |  |
| Olygose | Olygose is an independent French company that develops and produces a range of patented innovative ingredients extracted from various dietary plant-based raw materials such as processed heat-stable, sweet-tasting soluble fiber syrups of natural origin with full of nutritional benefits for the food and health industries. | $5.5M |  | Jan 05, 2015 |  |
| Ynsect | Ynsect provides products and services that operate in the agro-food and environmental biotech industries. It uses the potential of insect nutrients and behaviors to develop novel products and services in collaboration with their clients. Since 2011, Ÿnsect has been transforming farmed insects into premium animal nutrition. They are developinginnovations to farm insects at large scale and automating processes to turn insects into the highest quality raw materials for animal feed. Its unique know-how makes Ÿnsect a preferred partner among agri-food professionals, laboratories, investors, public institutions, and insect industry farmers. | $6M | Series B | Dec 17, 2014 |  |

10 of 25 investments shown.

## Co-investors
- [Demeter Partners](https://shizune.co/investors/profile/demeter-partners) — VC Fund, 8 deals together
- [CEA Investissement](https://shizune.co/investors/profile/cea-investments) — VC Fund, 5 deals together
- [ACG Management](https://shizune.co/investors/profile/viveris-management) — VC Fund, 3 deals together
- [Ace Capital Partners](https://shizune.co/investors/profile/ace-capital-partners) — VC Fund, 2 deals together
- [AQUITI Gestion](https://shizune.co/investors/profile/aquiti-gestion-aci) — VC Fund, 2 deals together
- [BNP Paribas Private Equity](https://shizune.co/investors/profile/bnp-paribas-private-equity) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in France](https://shizune.co/investors/biotechnology-investors-france)
- [Biotechnology VC Funds in France](https://shizune.co/investors/biotechnology-vc-funds-france)
- [Biotech Investors in France](https://shizune.co/investors/biotech-investors-france)
- [Biotech VC Funds in France](https://shizune.co/investors/biotech-vc-funds-france)
- [Climate Investors in France](https://shizune.co/investors/climate-investors-france)
- [Climate VC Funds in France](https://shizune.co/investors/climate-vc-funds-france)

## FAQ

### What does Emertec invest in?

Emertec invests primarily in Energy, Software and Electronics startups, most often at Series A and Funding Round stage. Most of the 25 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Emertec's check size?

Emertec typically joins rounds of $1.4M–$6.8M at Series A and $5.8M–$15M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Emertec participates in.

### How do I contact Emertec?

Public channels for Emertec include X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Emertec?

The team at Emertec includes Franck Lamy (Investment Manager) and Jean-Philippe Gendre (Member, Board of Directors). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co